Electrical Impedance Tomography for Assessment of Pulmonary Hypertension

Recruiting N/A Interventional Study
Pulmonary Hypertension Pulmonary Thromboembolisms
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
120 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Pulmonary hypertension is a serious and progressive disease that is difficult to treat and diagnose, mainly because its symptoms are nonspecific and often delay recognition. Early diagnosis is a major challenge. Although several tests may suggest the disease, the definitive diagnosis still requires right heart catheterization, an invasive procedure that directly measures pulmonary hemodynamics suc…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with a diagnosis or clinical suspicion of pulmonary arterial hypertension (PAH) and with a medical indication for right heart catheterization. * Patients evaluated at the Pulmonology Service of InCor-HCFMUSP. Exclusion Criteria: * Pregnancy. * Structural heart disea…
Contacts

Marcelo BP Amato, MD PhD

+55113061-7361

marcelo.amato@hc.fm.usp.br

CONTACT

Jade Lara de Melo, PT

+5534992911757

jade.l.melo.l@gmail.com

CONTACT